Posted inNews
Indian drugmaker Cipla tops Q2 profit view on solid domestic, N.America sales
By Kashish Tandon and Rishika SadamBENGALURU/HYDERABAD (Reuters) - Cipla, India's third-largest generic drug maker by sales, reported a better-than-expected quarterly profit on Friday, driven by…